Manipal Hospitals Raises Bid For Fortis Healthcare, Now Offers To Invest Rs 2,100 Crore. 10 Points
- Fortis has been the target of five companies and investment groups, who are vying for control of its 30-odd hospitals across India.Â
- The country's private healthcare market is expected to enjoy strong growth with the introduction of a new government insurance plan that is expected to make private healthcare more affordable for millions of poor families.
- Fortis has set up an advisory committee to evaluate the binding offers.Â
- Fortis board plans to meet on May 10 to consider the recommendations.
- Manipal has proposed to provide 21 billion rupees through preferential allotment of equity shares by Fortis, which needs funding to repay its existing loans and other commitments, the letter said.
- Earlier this month, Malaysia's IHH Healthcare Bhd lifted its offer to 175 rupees a share, while Indian businessmen Sunil Munjal and Anand Burman increased their combined offer to invest in the company to 18 billion rupees. Both these bidders are vying for partial equity stakes in the company.
- Radiant Life Care, backed by private equity firm KKR & Co, has also made a binding offer to acquire Fortis' Mumbai-based Mulund Hospital for an enterprise value of 12 billion rupees and a separate non-binding offer involving spin-off of diagnostic services arm SRL.
- China's Fosun International, the only one to have not revised its initial offer, had made a non-binding offer last month to invest up to $350 million subject to due diligence for a stake that would be less than 25 percent.
- Some investors are unhappy that the Manipal-led consortium has been given more time than rivals to match or top the rival bids and say they plan to vote against the group if it is selected as the winning bidder.
- The group, which initially reached an agreement with Fortis in March, before rival suitors made their interest public, had been given until May 6 to submit a bid, while the other four suitors were bound by a May 1 deadline.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.